Abiopharma

🔍 Gage Brodie (Executive)

Company: CIENA CORP (CIEN)

Report Date: 2026-03-20

Detailed Transactions and Holdings:

• Sold 230 shares of Common Stock at $383.89 per share (Direct)
  Date: 2026-03-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 53,043.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 204 shares of Common Stock at $383.89 per share (Direct)
  Date: 2026-03-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 52,839.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Sold 442 shares of Common Stock at $383.89 per share (Direct)
  Date: 2026-03-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 52,397.00 | transaction_form_type: 4 | Footnotes: F4, F2
• Sold 669 shares of Common Stock at $383.89 per share (Direct)
  Date: 2026-03-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 51,728.00 | transaction_form_type: 4 | Footnotes: F5, F2
• Sold 387 shares of Common Stock at $383.89 per share (Direct)
  Date: 2026-03-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 51,341.00 | transaction_form_type: 4 | Footnotes: F6, F2

Footnotes:

• F1: Represents shares withheld to cover payment of the tax liabilities of the reporting person related to a restricted stock unit (RSU) award agreement dated 12/16/2025. Acquisition of the RSU was previously reported in Table I of the reporting person's Form 4 filed on 12/18/2025.
• F2: Shares reported include unvested Restricted Stock Units (RSUs) and Performance Stock Units (PSUs).
• F3: Represents shares withheld to cover payment of the tax liabilities of the reporting person related to a restricted stock unit (RSU) award agreement dated 10/27/2023. Acquisition of the RSU was previously reported in Table I of the reporting person's Form 4 filed on 10/31/2023.
• F4: Represents shares withheld to cover payment of the tax liabilities of the reporting person related to a restricted stock unit (RSU) award agreement dated 12/13/2022. Acquisition of the RSU was previously reported in Table I of the reporting person's Form 3 filed on 10/31/2023.
• F5: Represents shares withheld to cover payment of the tax liabilities of the reporting person related to a restricted stock unit (RSU) award agreement dated 12/12/2023. Acquisition of the RSU was previously reported in Table I of the reporting person's Form 4 filed on 12/14/2023.
• F6: Represents shares withheld to cover payment of the tax liabilities of the reporting person related to a restricted stock unit (RSU) award agreement dated 12/17/2024. Acquisition of the RSU was previously reported in Table I of the reporting person's Form 4 filed on 12/19/2024.